← Back to Search

Memory Training for Mild Cognitive Impairment

N/A

Recruiting

Led By Nancy Chiaravalloti

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

60 or older.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed

Awards & highlights

Study Summary

This trial is testing whether a memory retraining program can help people with mild cognitive impairment (MCI). MCI is a common cognitive deficit that can negatively impact everyday life. The trial will test the effects of the memory retraining program on cognitive function and everyday life.

Who is the study for?

This trial is for individuals aged 60 or older who have been diagnosed with amnestic Mild Cognitive Impairment (MCI) and are fluent in English. It's not suitable for those with a history of stroke, neurological injuries/diseases, significant alcohol/drug abuse requiring inpatient treatment, use of benzodiazepines/steroids, or major psychiatric conditions like bipolar disorder or schizophrenia.Check my eligibility

What is being tested?

The study tests the effectiveness of memory retraining exercises compared to placebo control exercises on improving learning and memory in people with MCI. Participants will be randomly assigned to one of the two groups and assessed through neuropsychological tests, daily functioning questionnaires, and optional functional neuroimaging before and after treatment.See study design

What are the potential side effects?

Since this trial involves cognitive exercises rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during testing sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Select...

I am 60 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed

This trial's timeline: 3 weeks for screening, Varies for treatment, and four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participation in everyday life

Verbal list learning

Secondary outcome measures

Functional memory

Functional neuroimaging

Self-reported anxiety

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Experimental GroupExperimental Treatment1 Intervention

The experimental group will receive memory retraining exercises administered on a laptop computer twice a week for five weeks (10 training sessions).

Group II: Placebo Control GroupPlacebo Group1 Intervention

The placebo control group will receive placebo memory exercises administered on a laptop computer twice a week for five weeks (10 placebo control sessions).

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER

185 Previous Clinical Trials

601,858 Total Patients Enrolled

Kessler FoundationLead Sponsor

173 Previous Clinical Trials

10,588 Total Patients Enrolled

University of MichiganOTHER

1,797 Previous Clinical Trials

6,377,938 Total Patients Enrolled

Media Library

Memory Retraining Exercises Clinical Trial Eligibility Overview. Trial Name: NCT05396248 — N/A

Mild Cognitive Impairment Research Study Groups: Experimental Group, Placebo Control Group

Mild Cognitive Impairment Clinical Trial 2023: Memory Retraining Exercises Highlights & Side Effects. Trial Name: NCT05396248 — N/A

Memory Retraining Exercises 2023 Treatment Timeline for Medical Study. Trial Name: NCT05396248 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this investigation still available for individuals?

"Confirmed, according to clinicaltrials.gov this study is not presently recruiting patients; the trial was initiated on December 1st 2022 and its last update took place on October 12th 2022. Nevertheless, there are 573 additional medical trials that are currently seeking participants."

Answered by AI

What is the primary goal of this investigation?

"This clinical trial will assess the primary outcome of how participants interact in everyday life four times throughout: prior to treatment, directly after completion, and 6- and 18- months post. Secondary outcomes encompass changes on the Geriatric Depression Scale for self-reported depression levels, modifications to Virtual Reality Functional Capacity Assessment Tool (VRF-CAT) scores for functional memory capacity, and Quality of Life in Alzheimer's disease ratings for self-reported quality of life."

Answered by AI